Calculating and Allocating Drugs Costs
Dispensing Contractors
Financial Planning Guidance
Help With Health Costs
Hospital ePACT.net
PPD Publications
Information Services
New Contractual Framework for Community Pharmacy
Presc info/PMD Guidance
PCT Information
Pharmacy Contractor Payments
PPD Exhibitions
PPD Public Meetings
Prescription Form Product Area
Prescription Form Overprint Specifications
Prescription Forms Used by Nurse and Supplementary Prescribers
Processing and Pricing
Purchasing: Terms & Conditions
Quality
Repeat Dispensing Information
Resources
Safer Management of Controlled Drugs
Social Work Bursary
Resources
 
PPD
 

Repeat Dispensing as an Essential Service

The information provided here is for prescribers, dispensers and PCTs for repeat dispensing as an essential service within the new community pharmacy contract. The new contract came into force on the 1st April 2005. There are three main sections:

The Payment Process
The Submission Process
Reporting Information for PCTs

 


The Payment Process:
  1. Under the new pharmacy contract repeat dispensing is part of the essential services that all contractors are expected to provide. PCTs are not required to notify the Prescription Pricing Division of contractors who are taking part in repeat dispensing. From April 2005 the Drug Tariff provides details of how contractors will be paid for this service.

  2. In addition to the professional fee payable under Part IIIA for each item dispensed, all contractors will receive the following payment:


    • An annual payment of £1,500 paid as a £125 monthly payment


Process For Submitting Repeat Dispensing Forms

Prescribers

Repeat Dispensing involves the use of a repeatable prescription (authorising) form and a number of batch issue forms. These forms should be generated by prescribers through their GP practice systems.

  1. Repeatable Prescription (Authorising Forms)
    Only the authorising form must be signed by the prescriber.

    The forms must be FP10 prescription forms identifiable as Repeat Dispensing. Mock-ups of these forms can be found at http://www.ppa.org.uk/ppa/prescform_overspec.htm

    The authorising form should contain prescriber, patient and prescribed medicine details and include the number of issues required and the dispensing interval. This form must be signed by the prescriber.

  2. Batch Issue Forms
    The maximum number of batch issue forms is equivalent to 1 year duration of prescribing of an individual item. These forms should contain the same prescriber, patient and prescribed medicine details as the authorising forms and indicate in the prescribing area that the form is being used for Repeat Dispensing. Batch issue forms should not be signed, however, the prescriber’s signature box should be annotated with text displaying the words Repeat Dispensing: XX of YY, where XX is the number of the batch issue form and YY is the total number of batch issues covered by the repeatable prescription (e.g. 1 of 6, 3 of 12, etc.).

    NB The date on all of the batch issues and the repeat authorising form will be the same.

Dispensers

  1. Batch Issue Forms
    Dispensed batch issue forms should be submitted to the Prescription Pricing Division not later than the fifth day of the month following that in which the supply was made. They should be in their correct groups, i.e. exempt or charged groups, within the monthly batch of prescriptions. The order in which these forms are to be submitted will be detailed on submission form FP34C. Initial batch issue forms (i.e. 1 of x) need to be sorted separately from subsequent batch issue forms (i.e. 2 of x, 3 of x etc.), both sorted by doctor surname in alphabetical order.


    Batch issue forms which have not been dispensed should not be submitted to the Prescription Pricing Division. Any forms that become time expired should be destroyed.

  2. Repeat Authorising Forms
    Authorising forms should be submitted to the Prescription Pricing Division in the month following that in which all batch issue forms have either been dispensed or expired or the medication is no longer required. It is important that forms are sorted in the correct order (to be detailed on the reverse of the updated form FP34C) when submitted, as this could affect payment. If a submitted batch of prescriptions includes authorising forms this should be declared on the submission form FP34C by ticking the box next to Repeat Authorising forms.


  3. Endorsing Forms
    Each batch issue form should be endorsed as required in the Drug Tariff Part II Clause 9. In addition a batch issue form shall be stamped with the pharmacy’s stamp and dated with the date on which the items were dispensed.


Repeat Dispensing Reporting Information for PCTs

Monthly Repeat Dispensing report:
The online system used to provide the PCT report also provides a repeat dispensing report for PCTs. Once you have logged in to the system, you can select either the PCT Prescribing report or the new Repeat Dispensing report.

This Repeat Dispensing report shows the following information for each prescriber, by practice:

  • Practice Code and address.
  • Prescriber code and type.
  • Prescriber name.
  • Total items excluding ‘Batch Issue’ items.
  • Total Batch Issue items.
  • Percentage of total items that are ‘Batch Issue’ items.
  • Percentage of Batch Issue items that are on First ‘Batch Issue’ forms.
  • Percentage of Batch Issue items that are on Other ‘Batch Issue’ forms.
  • Total Cost excluding ‘Batch Issue’ items.
  • Total Cost of ‘Batch Issue’ items.
  • Percentage of total costs that are ‘Batch Issue’ item costs.

A total for each practice stating:

  • Total items excluding ‘Batch Issue’ items.
  • Total Batch Issue Items.
  • Percentage of total item that are ‘Batch Issue’ items.
  • Percentage of Batch Issue items that are on First ‘Batch Issue’ forms.
  • Percentage of Batch Issue items that are on Other ‘Batch Issue’ forms.
  • Total Cost excluding ‘Batch Issue’ items.
  • Total Cost of ‘Batch Issue’ items.
  • Percentage of total costs that are ‘Batch Issue’ item costs.

ePACT.net:
The ePACT.net system also provides the facility for PCT users to monitor and evaluate Repeat Dispensing by separately identifying first and other batch issues to individual drug level. This allows for analysis at PCT, practice and prescriber levels.

FEEDBACK:
We are trying to make the site as useful as possible to contractors and would like to invite your feedback to help achieve this. If there are areas which you feel could be explained more clearly, or there is any other information that you would have expected to see which we have not covered please email your comments to:

Jacqueline Johnson
jacqueline.johnson@ppa.nhs.uk

 


.

SearchBack to Top
   
  © NHS Business Services Authority
  Use of Personal Data - your rights, our responsibilities